PartsTable
Technical Data Sheet
Download PDF

2B0973 — LIDOCAINE HYDROCHLORIDE AND DEXT

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

2B0973: LIDOCAINE HYDROCHLORIDE AND DEXT.

LIDOCAINE HYDROCHLORIDE AND DEXT. Key specifications include administration: INTRAVENOUS, special_features: PREMIXED CONCENTRATION, primary_container_type: BAG, PLASTIC, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 12. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-148-7433, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
2B0973
NSN: 6505-01-148-7433
FSC: 6505 — Drugs and Biologicals
CAGE: 04687 — BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES (USA)
SPECIFICATIONS
administrationINTRAVENOUS
special_featuresPREMIXED CONCENTRATION
primary_container_typeBAG, PLASTIC
pharmaceutical_vehicle_typeAQUEOUS
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
total_primary_container_quantity12
primary_container_content_quantity500.000 MILLILITERS
active_medicament_medicinal_strength0.400 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
NSN6505-01-148-7433
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available LIDOCAINE HYDROCHLORIDE AND DEXT TITLE COMPONENT PN 2B0973 MFR LIDOCAINE HYDROCHLORID
KEY FEATURES
•
ADMINISTRATION: INTRAVENOUS
•
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: BAG, PLASTIC
•
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.400 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
•
TOTAL PRIMARY CONTAINER QUANTITY: 12
TECHNICAL CHARACTERISTICS
ADMINISTRATIONINTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY500.000 MILLILITERS
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPEBAG, PLASTIC
SPECIAL FEATURESPREMIXED CONCENTRATION
PHARMACEUTICAL VEHICLE TYPEAQUEOUS
ACTIVE MEDICAMENT MEDICINAL STRENGTH0.400 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY12
SUBSTITUTES & CROSS-REFERENCES 1
NDC00338-0409-03Reference document
Same NSN cross-reference
Reference document — Design control — primary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy 2B0973?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is 2B0973?
2B0973 is a LIDOCAINE HYDROCHLORIDE AND DEXT.
What parts can replace 2B0973?
There is 1 known substitute for 2B0973: NDC00338-0409-03. Substitute compatibility should be verified for your specific system.
What is the NSN for 2B0973?
2B0973 is cataloged in the U.S. Government catalog under NSN 6505-01-148-7433. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — 2B0973